| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Wenkui Li | |
| Francis L S Tse | |||
| P4510 | describes a project that uses | liquid chromatography-tandem mass spectrometry | Q117788892 |
| liquid chromatography–mass spectrometry | Q873864 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 49-65 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Biomedical Chromatography | Q4915104 |
| P1476 | title | Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules | |
| P478 | volume | 24 |
| Q46268194 | A DBS method for quantitation of the new oral trypanocidal drug fexinidazole and its active metabolites |
| Q49810962 | A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells |
| Q48017263 | A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS. |
| Q47735823 | A bioanalytical strategy utilizing dried blood spot sampling and LC-MS/MS in discovery toxicology studies |
| Q39985425 | A clinical validation study for application of DBS in therapeutic drug monitoring of antidepressants |
| Q52718389 | A database of avian blood spot examinations for exposure of wild birds to environmental toxicants: the DABSE biomonitoring project. |
| Q50016064 | A descriptive systematic review of salivary TDM in neonates and infants |
| Q39816351 | A glowing future for dried blood spot sampling. |
| Q50491603 | A novel approach to capillary plasma microsampling for quantitative bioanalysis. |
| Q36282140 | A novel freeze-dried storage and preparation method for the determination of mycophenolic acid in plasma by high-performance liquid chromatography. |
| Q39816327 | A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry |
| Q57052015 | A simple alternative sampling method for benznidazole pharmacokinetic assessment: a dried blood spot technique-based LC-MS/MS method |
| Q43943752 | A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS/MS. |
| Q57728123 | A validated LC–MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot |
| Q51749151 | Accurate weighing and dilution-assisted plasma microsampling (AWADA-PM): an easy-to-implement and rugged strategy. |
| Q29109543 | Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process |
| Q28083408 | Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS |
| Q53329867 | Amino acid analysis of dried blood spots for diagnosis of phenylketonuria using capillary electrophoresis-mass spectrometry equipped with a sheathless electrospray ionization interface. |
| Q51533867 | An automation-assisted generic approach for biological sample preparation and LC-MS/MS method validation. |
| Q51748947 | An industry perspective on tiered approach to the investigation of metabolites in drug development. |
| Q42716470 | Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry |
| Q57288446 | Analysis of insulin and insulin analogues from dried blood spots by means of LC-HRMS |
| Q42066076 | Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry |
| Q45400105 | Application of DBS for Quantitative Assessment of the Peptide Exendin-4; Comparison of Plasma and DBS Method by UHPLC–MS/MS |
| Q47191113 | Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioning |
| Q33810432 | Application of dried blood spot sampling combined with LC-MS/MS for genotyping and phenotyping of CYP450 enzymes in healthy volunteers |
| Q45519269 | Application of dried spot cards as a rapid sample treatment method for determining hydroxytyrosol metabolites in human urine samples. Comparison with microelution solid-phase extraction |
| Q33571450 | Assessing Volumetric Absorptive Microsampling Coupled with Stable Isotope Dilution Assay and Liquid Chromatography-Tandem Mass Spectrometry as Potential Diagnostic Tool for Whole Blood 5-Methyltetrahydrofolic Acid |
| Q50469847 | Assessment of the within- and between-lot variability of Whatman™ FTA(®) DMPK and 903(®) DBS papers and their suitability for the quantitative bioanalysis of small molecules |
| Q51291293 | Automated dried blood spots standard and QC sample preparation using a robotic liquid handler. |
| Q38980411 | Automated high throughput analysis of antiretroviral drugs in dried blood spots. |
| Q43508896 | Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry. |
| Q37890396 | Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS. |
| Q26739783 | Biomarkers for nutrient intake with focus on alternative sampling techniques |
| Q46306823 | Body fluid and tissue analysis using filter paper sampling support prior to LC-MS/MS: application to fatal overdose with colchicine |
| Q34619227 | Capillary microsampling in the regulatory environment: validation and use of bioanalytical capillary microsampling methods |
| Q45750494 | Capillary microsampling of 25 µl blood for the determination of toxicokinetic parameters in regulatory studies in animals |
| Q38259485 | Challenges and opportunities in mass spectrometric analysis of proteins from dried blood spots |
| Q38298357 | Challenges of analyzing different classes of metabolites by a single analytical method |
| Q42409840 | Characterization of the elemental composition of newborn blood spots using sector-field inductively coupled plasma-mass spectrometry |
| Q33470132 | Clinical Application of Ambient Ionization Mass Spectrometry |
| Q39885022 | Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4-Humanized Mouse Studies With PBPK Modeling |
| Q34150893 | Clinical evaluation of a dried blood spot assay for atazanavir |
| Q39231107 | Clinical perspectives of dried blood spot protein quantification using mass spectrometry methods. |
| Q28543246 | Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy |
| Q36277850 | Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration |
| Q48014832 | Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies |
| Q51073503 | Comparison of paper spray mass spectrometry analysis of dried blood spots from devices used for in-field collection of clinical samples. |
| Q37709919 | Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry |
| Q51170301 | Conference report: current bioanalytical topics from the ASMS conference 2011. |
| Q33723087 | Cotinine and trans 3'-hydroxycotinine in dried blood spots as biomarkers of tobacco exposure and nicotine metabolism |
| Q42806931 | DBS Sampling Can be Used to Stabilize Prodrugs in Drug Discovery Rodent Studies without the Addition of Esterase Inhibitors |
| Q38890687 | DBS-platform for biomonitoring and toxicokinetics of toxicants: proof of concept using LC-MS/MS analysis of fipronil and its metabolites in blood. |
| Q41290720 | Dating bloodstains with fluorescence lifetime measurements |
| Q90633011 | Determination of Antidepressants and Antipsychotics in Dried Blood Spots (DBSs) Collected from Post-Mortem Samples and Evaluation of the Stability over a Three-Month Period |
| Q42806899 | Determination of Naproxen Using DBS: Evaluation & Pharmacokinetic Comparison of Human Plasma Versus Human Blood DBS |
| Q53546561 | Determination of Synacthen(®) in dried blood spots for doping control analysis using liquid chromatography tandem mass spectrometry. |
| Q45257755 | Determination of ethyl glucuronide and ethyl sulfate from dried blood spots |
| Q42806923 | Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots |
| Q38140004 | Determination of pteridines in biological samples with an emphasis on their stability |
| Q53664909 | Determination of tamoxifen and endoxifen in dried blood spots using LC-MS/MS and the effect of coated DBS cards on recovery and matrix effects. |
| Q51755018 | Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS. |
| Q82483202 | Development and Validation of an HPLC–MS/MS Method for The Analysis of Dexamethasone from Pig Synovial Fluid Using Dried Matrix Spotting |
| Q38256679 | Development and validation of a dried blood spot assay for the quantification of ribavirin using liquid chromatography coupled to mass spectrometry |
| Q34380017 | Development and validation of a sensitive LC-MS/MS method for determination of tacrolimus on dried blood spots |
| Q34636168 | Development and validation of dried blood spots technique for quantitative determination of topiramate using liquid chromatography-tandem mass spectrometry |
| Q41716331 | Development of a UPLC-MS/MS method for the quantification of sildenafil by DBS, and its use on pediatric pulmonary hypertension |
| Q48368917 | Development of a dried blood spot HPLC-PDA method for the analysis of linezolid and ciprofloxacin in hospital-acquired pneumonia patients |
| Q35030893 | Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies. |
| Q44963401 | Direct analysis of dried blood spots by in-line desorption combined with high-resolution chromatography and mass spectrometry for quantification of maple syrup urine disease biomarkers leucine and isoleucine |
| Q37894587 | Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications. |
| Q38763889 | Discovery bioanalysis and in vivo pharmacology as an integrated process: a case study in oncology drug discovery |
| Q47735810 | Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS. |
| Q28384411 | Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide |
| Q58692660 | Dried Blood Spot Sampling with LC-MS Analysis for Routine Therapeutic Caffeine Monitoring in Neonates |
| Q63246774 | Dried Blood Spots for Global Health Diagnostics and Surveillance: Opportunities and Challenges |
| Q92711481 | Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation |
| Q40988516 | Dried blood spot analysis for rat and dog studies: validation, hematocrit, toxicokinetics and incurred sample reanalysis |
| Q36364155 | Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis |
| Q40881271 | Dried blood spot analysis for therapeutic drug monitoring of pazopanib |
| Q47612613 | Dried blood spot analysis of donepezil in support of a GLP 3-month dose-range finding study in rats |
| Q42930341 | Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole. |
| Q44713342 | Dried blood spot bioanalysis: an evaluation of techniques and opportunities for reduction and refinement in mouse and juvenile rat toxicokinetic studies |
| Q37018712 | Dried blood spot proteomics: surface extraction of endogenous proteins coupled with automated sample preparation and mass spectrometry analysis |
| Q49044992 | Dried blood spot punches for confirmation of suspected γ-hydroxybutyric acid intoxications: validation of an optimized GC-MS procedure |
| Q38130331 | Dried blood spots in bioanalysis of antimalarials: relevance and challenges in quantitative assessment of antimalarial drugs |
| Q37986127 | Dried blood spots in toxicology: from the cradle to the grave? |
| Q37859735 | Dried blood spots, pharmacokinetic studies and better medicines for children. |
| Q38201371 | Dried blood spots: concepts, present status, and future perspectives in bioanalysis |
| Q50047803 | Drug monitoring by volumetric absorptive microsampling: method development considerations to mitigate hematocrit effects |
| Q37713619 | Dynamic and temporal assessment of human dried blood spot MS/MSALL shotgun lipidomics analysis |
| Q47405189 | Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates. |
| Q39499484 | Effect of temperature on lysosomal enzyme activity during preparation and storage of dried blood spots. |
| Q38201783 | Emerging liquid chromatography-mass spectrometry technologies improving dried blood spot analysis |
| Q46441349 | Evaluation of dried blood spot (DBS) technology versus plasma analysis for the determination of MK-1775 by HILIC-MS/MS in support of clinical studies |
| Q44686846 | Evaluation of dried blood spots for the quantification of therapeutic monoclonal antibodies and detection of anti-drug antibodies |
| Q82482333 | Exploring the Feasibility of Using the DBS Technique for Metabolite Radioprofiling |
| Q39456871 | Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem®)-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study. |
| Q37872318 | GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples |
| Q38128343 | Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions |
| Q89726179 | Hematocrit, blood volume, and surface area of dried blood spots - a quantitative model |
| Q42940917 | High-throughput phospholipidic fingerprinting by online desorption of dried spots and quadrupole-linear ion trap mass spectrometry: evaluation of atherosclerosis biomarkers in mouse plasma |
| Q36452369 | How to optimize the evaluation and use of antibiotics in neonates |
| Q42806912 | Human DBS Sampling with LC–MS/MS for Enantioselective Determination of Metoprolol and its Metabolite O -Desmethyl Metoprolol |
| Q41984975 | Impact of various factors on radioactivity distribution in different DBS papers |
| Q43192927 | Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group |
| Q82483135 | Increasing Efficiency for Dried Blood Spot Analysis: Prospects for Automation and Simplified Sample Analysis |
| Q47818503 | Instant on-paper protein digestion during blood spot sampling |
| Q41666745 | Integrated Metabolomics Assessment of Human Dried Blood Spots and Urine Strips. |
| Q51579422 | Internal standard tracked dilution to overcome challenges in dried blood spots and robotic sample preparation for liquid chromatography/tandem mass spectrometry assays. |
| Q64136491 | Investigation of dried blood sampling with liquid chromatography tandem mass spectrometry to confirm human exposure to nerve agents |
| Q87426856 | Investigation of endogenous blood lipids components that contribute to matrix effects in dried blood spot samples by liquid chromatography-tandem mass spectrometry |
| Q56794668 | LC-MS/MS method for the simultaneous determination of tenofovir, emtricitabine, elvitegravir and rilpivirine in dried blood spots |
| Q48246835 | Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation. |
| Q34979638 | Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS/MS quantification |
| Q38187157 | Methods for pharmacokinetic analysis in young children |
| Q37841718 | Microassay of drugs and modern measurement techniques |
| Q42183242 | Multiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots |
| Q40167311 | Multiplexed extraction and quantitative analysis of pharmaceuticals from DBS samples using digital microfluidics |
| Q36666389 | Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometry |
| Q87166088 | One mouse, one pharmacokinetic profile: quantitative whole blood serial sampling for biotherapeutics |
| Q83213156 | Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot |
| Q34051083 | Performance and storage integrity of dried blood spots for PCB, BFR and pesticide measurements |
| Q38985344 | Personalized monitoring of therapeutic salicylic acid in dried blood spots using a three-layer setup and desorption electrospray ionization mass spectrometry. |
| Q82483142 | Pharmacokinetic Considerations as to When to Use Dried Blood Spot Sampling |
| Q30249512 | Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review |
| Q90637813 | Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers |
| Q51275877 | Preclinical bridging studies: understanding dried blood spot and plasma exposure profiles. |
| Q38266632 | Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review |
| Q51174001 | Quantification by nano liquid chromatography parallel reaction monitoring mass spectrometry of human apolipoprotein A-I, apolipoprotein B, and hemoglobin A1c in dried blood spots. |
| Q39833392 | Quantification of Warfarin in Dried Rat Plasma Spots by High-Performance Liquid Chromatography with Tandem Mass Spectrometry |
| Q47688683 | Quantitation of salbutamol using micro-volume blood sampling - applications to exacerbations of pediatric asthma |
| Q37347434 | Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS. |
| Q45323294 | Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery |
| Q48193600 | Quantitative analysis of clofazimine (Lamprene®), an antileprosy agent, in human dried blood spots using liquid chromatography-tandem mass spectrometry. |
| Q39745272 | Quantitative analysis of methyl and propyl parabens in neonatal DBS using LC-MS/MS. |
| Q51564201 | Rapid Isolation and Determination of Flavones in Biological Samples Using Zinc Complexation Coupled with High-Performance Liquid Chromatography. |
| Q53128171 | Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment. |
| Q92076225 | Rapid electrophoretic recovery of DNA from dried blood spots |
| Q38153802 | Recent advances in the bioanalytical applications of dried matrix spotting for the analysis of drugs and their metabolites |
| Q59794445 | Reinventing (Bio)chemical Analysis with Paper |
| Q47387427 | Semi-automated direct elution of dried blood spots for the quantitative determination of guanfacine in human blood |
| Q82483225 | Sensitive Determination of a Drug Candidate in Dried Blood Spots Using a TLC–MS Interface Integrated into a Column-Switching LC–MS/MS System |
| Q45854049 | Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer |
| Q55063522 | Simultaneous Determination of Phenobarbital, Pentobarbital, Amobarbital and Secobarbital in Raw Milk via Liquid Chromatography with Electron Spray Ionization Tandem Mass Spectrometry. |
| Q64104944 | Simultaneous Determination of Selegiline, Desmethylselegiline, R/S-methamphetamine, and R/S-amphetamine on Dried Urine Spots by LC/MS/MS: Application to a Pharmacokinetic Study in Urine |
| Q35681653 | Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots |
| Q34079084 | Simultaneous quantification of centchroman and its 7-demethylated metabolite in rat dried blood spot samples using LC-MS/MS. |
| Q38266512 | Spot them in the spot: analysis of abused substances using dried blood spots. |
| Q39397563 | Stability of metabolites in dried blood spots stored at different temperatures over a 2-year period |
| Q38130332 | State-of-the-art dried blood spot analysis: an overview of recent advances and future trends. |
| Q43893844 | Stepwise optimization approach for improving LC-MS/MS analysis of zwitterionic antiepileptic drugs with implementation of experimental design. |
| Q58805777 | The Use of Dried Blood Spots for the Quantification of Antihypertensive Drugs |
| Q53090233 | The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. |
| Q47909387 | The use of a membrane filtration device to form dried plasma spots for the quantitative determination of guanfacine in whole blood |
| Q49051614 | The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography - tandem mass spectrometry. |
| Q38253959 | The use of mass spectrometry to analyze dried blood spots |
| Q38874510 | Towards reproducible MRM based biomarker discovery using dried blood spots |
| Q42806889 | Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. |
| Q48221188 | Use of conventional bioanalytical devices to automate DBS extractions in liquid-handling dispensing tips |
| Q48860532 | Use of dried blood spots for the determination of serum concentrations of tamoxifen and endoxifen |
| Q42739574 | Use of dried blood spots in drug development: pharmacokinetic considerations |
| Q36910958 | Use of dried plasma spots for the quantification of iothalamate in clinical studies |
| Q30922388 | Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies |
| Q45998866 | Utilization of DBS Within Drug Discovery: Development of a Serial Microsampling Pharmacokinetic Study in Mice |
| Q45194954 | Utilization of dried blood spots within drug discovery: modification of a standard DiLab(®) AccuSampler(®) to facilitate automatic dried blood spot sampling |
| Q42590076 | Utilizing Internal Standard Responses to Assess Risk on Reporting Bioanalytical Results from Hemolyzed Samples |
| Q46474927 | Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots. |
| Q42806737 | Validation of Individual Quantitative Methods for Determination of Cytochrome P450 Probe Substrates in Human Dried Blood Spots with HPLC–MS/MS |
| Q82483218 | Validation of a High-Sensitivity Assay for Zatebradine in Dried Blood Spots of Human Blood at Pg/Ml Concentrations Using HILIC–MS/MS |
| Q33770850 | Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS. |
| Q39523488 | Validation of a ligand binding assay using dried blood spot sampling |
| Q43974085 | What are the challenges of stability investigations and sample stabilization in regulated bioanalysis? |
| Q39558718 | What is next for dried blood spots? |
| Q50584403 | What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis? |
| Q23918895 | Whole blood is the sample matrix of choice for monitoring systemic triclocarban levels |
| Q49060953 | Why dried blood spots are an ideal tool for CYP1A2 phenotyping |
Search more.